Uh-oh, he’s back: Fauci is once again spouting bad COVID advice

Uh-oh, he’s back: Fauci is once again spouting bad COVID advice
Photo Credit: Kevin Dietsch-Pool/Getty Images

Controversial ex-COVID czar Anthony Fauci reemerged this week to urge that, because of rising infection rates, we consider a return to comprehensive masking protocols. That’s bad health-care policy, because it doesn’t follow the science. No wonder nobody’s listening to Dr. Fauci.

Let’s face it: public-health messaging and open, honest debate haven’t been the Good Doctor’s strong suits. He’s the wrong man, at the wrong time, with the wrong advice. But the big problem is a misunderstanding of what’s actually going on.

Following large-scale vaccination efforts and the introduction of the various Omicron variants, states and municipalities with more robust masking regulations have not fared better than those with more targeted strategies for reducing the prevalence of serious disease. Even with today’s significantly more infectious COVID-19 strains, the number of serious viral manifestations remain very low — and, in the majority, most of them impact unvaccinated and high-risk individuals.

So whether or not masking was good at preventing the spread of COVID before vaccines became available, it certainly is not so today. And it’s doubly foolish to use infection rates to trigger a return to widespread masking. Prior to mass vaccination, such rates were an excellent predictor of both hospitalization and death rates; today, they’re still an important data point — but they’re no longer a key indicator of public-health danger.
 
Sign Up for Our Email Newsletter

RECENT NEWS

Sorry, but the ‘drugs from Canada’ don’t work

Sorry, but the ‘drugs from Canada’ don’t work

“Drugs from Canada” is a policy that won’t work. And a political soundbite that won’t die....  Read more

Product Failure Is Not Process Failure

Product Failure Is Not Process Failure

FDA be nimble. FDA be quick. FDA jump over the bureaucratic schtick....  Read more

The Future of U.S. Biopharmaceutical Innovation and Supply Chain Security Lies in the Abraham Accords Region

The Future of U.S. Biopharmaceutical Innovation and Supply Chain Security Lies in the Abraham Accords Region

Congress must enact legislation that pushes our country forward, builds bridges where there are gaps, and leverages strat...  Read more

DRUGWONKS BLOG